January Is Cervical Cancer Month - Article From JhpiegoImagine being diagnosed with a preventable disease in a country where access to quality health care services is not available to you. Not because you live in a remote area or because people don't care, but because the training was not available for the skilled healthcare providers treating you. Now imagine being an HIV positive woman in this country. You may have another preventable disease that can also kill you and you don't even know about it - cervical cancer.
January Is Cervical Cancer Awareness Month - Commonwealth Of KentuckyMore women in Kentucky should join the fight to end cervical cancer by getting vaccinated and undergoing regular screenings for the disease, the Kentucky Department for Public Health (DPH) announced today. Women age 9 to 26 years old can receive a vaccine to prevent the human papillomavirus (HPV) linked to cervical cancer. Gardasil, the HPV vaccine, is viewed as one of the most significant women's health developments in recent years.
Department Of Health Recognizes January As Cervical Health Awareness MonthAs a part of National Cervical Health Awareness Month, Acting Secretary of Health Everette James today reminded women of the importance of cervical cancer prevention and the need for pap tests. "Every January as we begin a new year, we want to remind all Pennsylvanians to do what they can to improve their overall health," said James.
Denise Galloway And Gerald Smith Named AAAS FellowsFred Hutchinson Cancer Research Center scientists Denise Galloway, Ph.D., a microbiologist, and Gerald Smith, Ph.D., a geneticist and microbiologist, have been awarded the distinction of AAAS Fellow. Election as a Fellow is an honor bestowed upon members of the American Association for the Advancement of Science, or AAAS, by their peers.
High HPV Vaccination Coverage Already Achieved In EnglandMore than 70 per cent of 12-13 year old girls have already had their first HPV (human papillomavirus) jab since the vaccination campaign started in September, Public Health Minister Dawn Primarolo announced today. This figure will rise as more results come in. The success of the campaign has prompted the Department of Health to announce that the catch up campaign to vaccinate girls aged 13-17 years will be brought forward to next year.
INVIRION Diagnostics Launches Successful Hybrid Instrument At EUROGIN 2008 INVIRION Diagnostics, LLC, successfully launched their new Molecular Hybrid Platform (MoHP) at EUROGIN 2008 (European Research Organization on Genital Infection and Neoplasia). EUROGIN is the leading international multidisciplinary organization involved in research, training, screening, prevention and information concerning genital infections, pre-cancers and cancers in women.
Fears Of Promiscuity Pose Barrier To Cervical Cancer VaccinationsThe public's concerns about costs and increased promiscuity among teenagers appear to be hindering use of a vaccine against the human papilloma virus (HPV) to prevent life-threatening diseases, according to a study by researchers at Yale School of Public Health.
Irish Advocates Call For Government To Reinstate HPV Vaccination PlanSome women's health advocates in Ireland are protesting a decision last month by Minister for Health Mary Harney to cancel the government's plan to vaccinate all 12-year-old girls against human papillomavirus, the Irish Times reports. More than 10,000 people have joined a group on the social networking Web site Facebook that calls for Harney to reinstate the program.
January Is Cervical Health Awareness MonthAccording to the American Cancer Society, 3,870 mothers, daughters, and wives will die from cervical cancer in 2008. Over 11,000 new cases of cervical cancer will be diagnosed by year's end. The Cancer Institute of New Jersey (CINJ) is making experts available to discuss risk factors, treatment and prevention options surrounding cervical cancer. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
GlaxoSmithKline To Reduce Price Of HPV Vaccine Cervarix In South AfricaGlaxoSmithKline on Wednesday announced it will reduce the cost of its human papillomavirus vaccine Cervarix in South Africa, SAPA/Independent Online reports. GSK will reduce the price of the vaccine from 700 South African rand per dose, or about $67, to 450 rand per dose, or about $43.
BD Receives FDA Approval For The BD FocalPoint(TM) GS Imaging System To Enhance The Detection Of Cervical CancerBD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System. This innovative new system is designed to enhance cervical cancer screening for cytology laboratories using the BD SurePath(TM) Pap test slides to detect evidence of squamous carcinoma, adenocarcinoma and their usual precursor conditions.
![](\"http://www.igotyourindex.com/igyindex.gif?DOCUMENTNAME=&DOCUMENTLINK=&GOALNAME&=DOCUMENTVALUE&=GROUPNAME\")